Portfolio Curator News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Portfolio curator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Portfolio Curator Today - Breaking & Trending Today

Vancouver-based SaNOtize Raises $24 Million in Series-B Financing to Advance Its Nitric Oxide-Based Therapeutics

Vancouver-based SaNOtize Raises $24 Million in Series-B Financing to Advance Its Nitric Oxide-Based Therapeutics. Vancouver, BC, August 26, 2022 Vancouver-based SaNOtize Research & Development Corp., an anti-infective-focused therapeutics company, announced an oversubscribed $24 million Series-B funding round to advance its nitric oxide-based therapeutics pipeline. ....

United States , Hong Kong , British Columbia , Sri Lanka , Chris Miller , Frances Kang , Jon Medved , Gilly Regev , Sanotize Co , European Union , Vancouver Basedsanotize Research Development Corp , Lancet Regional Health Southeast Asia , Central Drugs Standard Control Organization , Seriesb Funding , Advance Its Nitric Oxide Based Therapeutics , Including Nasal Spray , Development Corp , Lancet Regional Health Southeast , Horizons Ventures , Nitric Oxide Releasing Solution , Portfolio Curator , Chief Scientific Officer ,

SaNOtize Raises $24M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Hong Kong , British Columbia , Sri Lanka , Chris Miller , Frances Kang , Gilly Regev , Sanotize Research Development Corp , Agricultural Bank , European Union , Central Drugs Standard Control Organization , China International , Development Corp , Horizons Ventures , Portfolio Curator , Chief Scientific Officer , Nitric Oxide Nasal Spray , United States ,

SaNOtize Research & Development Corp.: SaNOtize Announces $24 Million in Series B Funding to Advance Its Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19

Co-led by Horizons Ventures and OurCrowd, new funding enables SaNOtize to invest in its ongoing Phase 3 clinical trial for COVID-19 prevention and enhance clinical development of its other nitric ....

United States , Hong Kong , British Columbia , Sri Lanka , Chris Miller , Kostenloser Wertpapierhandel , Frances Kang , Sean Gjos , Jon Medved , Gilly Regev , Sanotize Co , Lancet Regional Health Southeast Asia , Central Drugs Standard Control Organization , Sanotize Research Development Corp , European Union , Business Development , Horizons Ventures , Nitric Oxide Nasal Spray , Middle East , Research Development Corp , Lancet Regional Health Southeast , Nitric Oxide Releasing Solution , Portfolio Curator , Chief Scientific Officer , Research Development ,